Propanc Biopharma, Inc. (OTCMKTS:PPCB) Short Interest Update

Propanc Biopharma, Inc. (OTCMKTS:PPCBGet Rating) saw a large drop in short interest during the month of April. As of April 30th, there was short interest totalling 17,300 shares, a drop of 94.8% from the April 15th total of 331,900 shares. Based on an average daily volume of 6,696,900 shares, the days-to-cover ratio is currently 0.0 days.

Shares of PPCB traded up $0.00 during mid-day trading on Thursday, reaching $0.01. The company had a trading volume of 17,107,868 shares, compared to its average volume of 2,070,145. The firm has a fifty day simple moving average of $0.01 and a 200-day simple moving average of $0.02. Propanc Biopharma has a fifty-two week low of $0.01 and a fifty-two week high of $0.16.

Propanc Biopharma (OTCMKTS:PPCBGet Rating) last posted its earnings results on Monday, February 14th. The company reported ($0.02) earnings per share for the quarter.

About Propanc Biopharma (Get Rating)

Propanc Biopharma, Inc, a biopharmaceutical company, focuses on the development of cancer treatments for patients with pancreatic, ovarian, and colorectal cancer in Australia. Its lead product is PRP, a formulation that is in preclinical phase of development designed to enhance the anti-cancer effects of multiple enzymes acting synergistically.

Recommended Stories

Receive News & Ratings for Propanc Biopharma Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Propanc Biopharma and related companies with MarketBeat.com's FREE daily email newsletter.